Ma XWR. Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update. Int J Pharm Investig. 2018;48:61–75.

Article  CAS  Google Scholar 

Chen G, Kang W, Li W, Chen S, Gao Y. Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies. Theranostics. 2022;12(3):1419–39.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen TXHL, Gauthier M, Yang G, Wang Q. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine (Lond). 2016;11:1169–85.

Article  CAS  PubMed  Google Scholar 

Shi GGW, Stephenson SM, Lee RJ. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release. 2002;80:309–19.

Article  CAS  PubMed  Google Scholar 

Lai SKWY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61:158–71.

Article  CAS  PubMed  Google Scholar 

Ensign LMSC, Suk JS, Cone R, Hanes J. Mucus penetrating panoparticles: biophysical tool and method of drug and gene delivery. AdvMater. 2012;24:3887–94.

CAS  Google Scholar 

Yang MLS, Wang YY, Zhong W, Happe C, Zhang M, Fu J, Hanes J. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem, Int Ed. 2011;50:2597–600.

Article  CAS  Google Scholar 

Verma ASF. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6:12–21.

Article  CAS  PubMed  Google Scholar 

Bennett CFCM, Chan H, Shoemaker JE, Mirabelli CK. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharm. 1992;41:1023–33.

CAS  Google Scholar 

Sahoo SKPJ, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105–14.

Article  CAS  PubMed  Google Scholar 

Boegh MNH. Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116:179–86.

Article  CAS  PubMed  Google Scholar 

Ra C. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61:75–85.

Article  Google Scholar 

Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28–51.

Article  CAS  PubMed  Google Scholar 

Shan W, Zhu X, Tao W, Cui Y, Liu M, Wu L, et al. Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers. ACS Appl Mater Interfaces. 2016;8(38):25444–53.

Article  CAS  PubMed  Google Scholar 

Zhang X, Cheng H, Dong W, Zhang M, Liu Q, Wang X, et al. Design and intestinal mucus penetration mechanism of core-shell nanocomplex. J Control Release. 2018;272:29–38.

Article  CAS  PubMed  Google Scholar 

Brunner JRS, Borchard G. Target specific tight junction modulators. Adv Drug Deliv Rev. 2021;171:266–88.

Article  CAS  PubMed  Google Scholar 

Odenwald MATJ. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14:9–21.

Article  CAS  PubMed  Google Scholar 

Prado HJMM. Cationization of polysaccharides: A path to greener derivatives with many industrial applications. Eur Polymer J. 2014;52:53–75.

Article  CAS  Google Scholar 

Anselmo ACGY, Mitragotri S. Non-invasive delivery strategies for biologics. Nat Rev Drug Discov. 2019;18:19–40.

Article  CAS  PubMed  Google Scholar 

Fan WXD, Zhu Q, Hu L, Gan Y. Intracellular transport of nanocarriers across the intestinal epithelium. Drug Discov Today. 2016;21:856–63.

Article  CAS  PubMed  Google Scholar 

Han XZE, Shi Y, Song B, Du H, Cao Z. Biomaterial-tight junction interaction and potential impacts. J Mater Chem B. 2019;7:6310–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gopalakrishnan SPN, Tamiz AP, Vere J, Carrasco R, Somerville R, Tripathi A, Ginski M, Paterson BM, Alkan SS. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int J Pharm. 2009;365:121–30.

Article  CAS  PubMed  Google Scholar 

Li MOE, Kitchens KM, Vere J, Alkan SS, Tamiz AP. Structure-activity relationship studies of permeability modulating peptide AT-1002. Bioorg Med Chem Lett. 2008;18:4584–6.

Article  CAS  PubMed  Google Scholar 

Wang JYV, Smart AL, Tajiri AW. Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs. Mol Pharm. 2015;12:966–73.

Article  CAS  PubMed  Google Scholar 

Wang XSZ, Wei S, Ji G, Zheng X, Fu Z, Cheng J. Polypeptide-based drug delivery systems for programmed release. Biomaterials. 2021;275:120913.

Article  CAS  PubMed  Google Scholar 

Miles AJJR, Wallace BA. Tools and methods for circular dichroism spectroscopy of proteins: a tutorial review. Chem Soc Rev. 2021;50:8400–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahzadi I, Dizdarevic A, Efiana NA, Matuszczak B, Bernkop-Schnurch A. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation. J Colloid Interface Sci. 2018;531:253–60.

Article  CAS  PubMed  Google Scholar 

Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, et al. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnology. 2021;19(1):32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kararli T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16(5):351–80.

Article  CAS  PubMed  Google Scholar 

Wang A, Yang T, Fan W, Yang Y, Zhu Q, Guo S, et al. Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers. Adv Healthc Mater. 2018;8(12).

Ding R, Zhao Z, He J, Tao Y, Zhang H, Yuan R, et al. Preparation, drug distribution, and in vivo evaluation of the safety of protein corona liposomes for liraglutide delivery. Nanomaterials (Basel). 2023;13(3):540.

Article  CAS  PubMed  Google Scholar 

Szmola R, Kukor Z, Sahin-Toth M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem. 2003;278(49):48580–9.

Article  CAS  PubMed  Google Scholar 

Uchida T, Kanazawa T, Takashima Y, Okada H. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002. Chem Pharm Bull. 2011;59:196–201.

Article